Raymond James Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.12M | Buy |
|
|||||
|
2024
Q2 | $1.09M | Sell |
|
|||||
|
2024
Q1 | $1.01M | Buy |
|
|||||
|
2023
Q4 | $841K | Buy |
|
|||||
|
2023
Q3 | $710K | Buy |
|
|||||
|
2023
Q2 | $487K | Buy |
|
|||||
|
2023
Q1 | $549K | Buy |
|
|||||
|
2022
Q4 | $433K | Sell |
|
|||||
|
2022
Q3 | $490K | Buy |
|
|||||
|
2022
Q2 | $405K | Sell |
|
|||||
|
2022
Q1 | $583K | Sell |
|
|||||
|
2021
Q4 | $561K | Buy |
|
|||||
|
2021
Q3 | $521K | Buy |
|
|||||
|
2021
Q2 | $440K | Sell |
|
|||||
|
2021
Q1 | $407K | Sell |
|
|||||
|
2020
Q4 | $776K | Sell |
|
|||||
|
2020
Q3 | $919K | Sell |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | $509K | Buy |
|
|||||
|
2019
Q4 | $300K | Buy |
|
|||||
|
2019
Q3 | $214K | Buy |
|
|||||
|
2019
Q2 | $224K | Buy |
|
|||||
|
2019
Q1 | $266K | Sell |
|
|||||
|
2018
Q4 | $337K | Sell |
|
|||||
|
2018
Q3 | $374K | Sell |
|
|||||
|
2018
Q2 | $320K | Buy |
|
|||||
|
2018
Q1 | $283K | Buy |
|
|||||
|
2017
Q4 | $293K | Sell |
|
|||||
|
2017
Q3 | $370K | Sell |
|
|||||
|
2017
Q2 | $441K | Buy |
|
|||||
|
2017
Q1 | $320K | Buy |
|
|||||
|
2016
Q4 | $279K | Buy |
|
|||||
|
2016
Q3 | $278K | Buy |
|